インフォショップ ホームへ 株式会社グローバルインフォメーション
サイトマップ
その他のカテゴリ

商品カタログ

医療/バイオの調査資料販 MEDINFO.JP

バイオシミラー特集
バイオシミラー特集ページ バイオシミラーに関連したレポートを紹介致します。

Global Pharmaceuticals Research & Manufacturing 公式サイト

Translational Cancer Medicine 公式サイト

Outsourcing Asia Summit 2009 公式サイト

Global Healthcare Congress 2009 公式サイト

BioMedical Asia 2009 公式サイト

China 2009 Pharmaceutical R&D Summit 公式サイト

Drug Discovery & Development of Innovative Therapeutics Japan 2009 公式サイト

Drug Discovery & Development of Innovative Therapeutics 2009 公式サイト
English Korean Chinese
【 英文市場調査報告書 】

中国におけるOTC医薬品市場

OTC Healthcare in China

商品コード : 60369 Euromonitor International
出版日 : 2007/09
発行 : Euromonitor International
電話でのお問い合わせ
価格情報
概要 原文目次
※この商品は英文にてご提供いたします。

Abstract

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Product coverage

Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments

Executive summary

Strong growth due to rising incomes and awareness

There was strong growth across OTC healthcare in 2006. Growth was supported by continued expansion in the Chinese economy, with rising income levels enabling consumers to buy more OTC healthcare. This drove growth in basic products such as analgesics and cough, cold and allergy (hay fever) remedies. Rising incomes also resulted in richer and less healthy diets, boosting digestive remedies, while increased pollution supported growth in allergy remedies and medicated skin care. In addition, consumers became more aware of OTC healthcare and more confident in self-medication, while health and wellness trends boosted vitamins and dietary supplements. Consumers also became more confident in discussing once-taboo ailments, with this boosting products such as vaginal antifungals and haemorrhoid treatments.

Emergency contraception benefits from government campaigns

Emergency contraception saw the strongest current value growth in 2006 over the previous year. Growth was supported by strong government campaigns and by advertising. As condoms cannot currently be advertised in the country, emergency contraception was left with a distinct advantage. In addition, women generally became more confident and affluent during the review period, leaving them in a better position to direct their own birth control.

Amway leads despite difficulties

Amway remained the leading player in 2006, with a share considerably higher than any of its competitors. This was despite seeing a sharp drop in share over 2005, as it attempted to reconcile its sales representatives to a new business structure in line with new direct sales legislation. Amway is only present in vitamins and dietary supplements, which dominates overall OTC healthcare. Direct sales is particularly strong in vitamins and dietary supplements, due to its representatives being able to offer individual guidance to often-confused customers and with distribution expanding rapidly across the country.

Specialist channels continue to dominate

Chemists/pharmacies and drugstores/parapharmacies jointly dominated value sales of OTC healthcare in 2006. Many OTC healthcare products are indeed only permitted for sale via these channels. However, these channels both lost share during the review period as distribution widened for many products. Discounters notably gained share across OTC healthcare in the latter half of the review period, as this channel' s low prices appealed to price-sensitive consumers. Direct sales also gained share rapidly, due to its growing presence in dominant vitamins and dietary supplements.

Good growth to continue as distribution and self-medication widens

OTC healthcare is expected to see slower but still strong growth during the forecast period. Many products are seeing increasing maturity in larger cities, notably analgesics and vitamins and dietary supplements, with this expected to dampen growth. Growth will continue to be supported by distribution widening to include smaller cities and rural areas, however. In addition, growth will be boosted by consumers' growing confidence in self-medication, with most happy to choose basic OTC healthcare themselves.

Table of Contents

  • OTC HEALTHCARE IN CHINA : MARKET INSIGHT
  • EXECUTIVE SUMMARY
  • Strong growth due to rising incomes and awareness
  • Emergency contraception benefits from government campaigns
  • Amway leads despite difficulties
  • Specialist channels continue to dominate
  • Good growth to continue as distribution and
  • self-medication widens
  • KEY TRENDS AND DEVELOPMENTS
  • Rising income levels boost sales
  • Traditional Chinese medicine continues to grow in popularity
  • Growing interest in self-medication and health and wellness
  • Grooming and appearance become increasingly important
  • Specialist channels see dominance eroded
  • TERRITORY KEY TRENDS AND DEVELOPMENTS
  • East China
  • Mid China
  • North and Northeast China
  • Northwest China
  • South China
  • Southwest China
  • MARKET INDICATORS
    • Table 1 Life Expectancy at Birth 2001-2006
  • MARKET DATA
    • Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
    • Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
    • Table 4 Sales of OTC Healthcare by Region: Value 2001-2006
    • Table 5 Sales of OTC Healthcare by Region: % Value Growth 2001-2006
    • Table 6 OTC Healthcare Company Shares by Retail Value 2002-2006
    • Table 7 OTC Healthcare Brand Shares by Retail Value 2003-2006
    • Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
    • Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
    • Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
    • Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
    • Table 12 Forecast Sales of OTC Healthcare by Region: Value 2006-2011
    • Table 13 Forecast Sales of OTC Healthcare by Region: % Value Growth 2006-2011
  • APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Generics
  • Consumer expenditure on health goods and medical services
  • Consumer Expenditure on Health Goods and Medical Services
    • Table 14 Consumer Expenditure on Health Goods and Medical Services 2001-2006
  • DEFINITIONS
  • Sources
    • Summary 1 Research Sources
  • LOCAL COMPANY PROFILES - CHINA
  • AMWAY (CHINA) CO LTD - OTC HEALTHCARE - CHINA
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 2 Amway (China) Co Ltd: Key Facts
  • COMPANY BACKGROUND
  • PRODUCTION
  • COMPETITIVE POSITIONING
    • Summary 3 Amway (China) Co Ltd: Competitive Position 2006
  • BRISTOL-MYERS SQUIBB CO - OTC HEALTHCARE - CHINA
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 4 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Key Facts
    • Summary 5 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
  • COMPETITIVE POSITIONING
    • Summary 6 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Competitive Position 2006
  • GUANGZHOU PAN GAO SHOU PHARM CO LTD - OTC HEALTHCARE - CHINA
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 7 Guangzhou Pan Gao Shou Pharm Co Ltd: Key Facts
    • Summary 8 Guangzhou Pan Gao Shou Pharm Co Ltd: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
    • Summary 9 Guangzhou Pan Gao Shou Pharm Co Ltd: Production Statistics 2006
  • COMPETITIVE POSITIONING
    • Summary 10 Guangzhou Pan Gao Shou Pharm Co Ltd: Competitive Position 2006
  • HARBIN PHARMACEUTICAL GROUP SANJING PHARM CO LTD - OTC
  • HEALTHCARE - CHINA
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 11 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Key Facts
    • Summary 12 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
  • COMPETITIVE POSITIONING
    • Summary 13 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Competitive Position 2006
  • KUNMING DIANHONG PHARM CO LTD - OTC HEALTHCARE - CHINA
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 14 Kunming Dianhong Pharm Co Ltd: Key Facts
    • Summary 15 Kunming Dianhong Pharm Co Ltd: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
  • COMPETITIVE POSITIONING
    • Summary 16 Kunming Dianhong Pharm Co Ltd: Competitive Position 2006
  • SHANGHAI JIAO DA ONLLY CO LTD - OTC HEALTHCARE - CHINA
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 17 Shanghai Jiao Da Onlly Co Ltd: Key Facts
    • Summary 18 Shanghai Jiao Da Onlly Co Ltd: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
    • Summary 19 Shanghai Jiao Da Onlly Co Ltd: Production Statistics 2006
  • COMPETITIVE POSITIONING
    • Summary 20 Shanghai Jiao Da Onlly Co Ltd: Competitive Position 2006
  • TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT CO LTD - OTC HEALTHCARE - CHINA
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 21 Tianjin Tianshi Biological Development Co Ltd: Key Facts
  • COMPANY BACKGROUND
  • PRODUCTION
  • COMPETITIVE POSITIONING
    • Summary 22 Tianjin Tianshi Biological Development Co Ltd: Competitive Position 2006
  • TIBET LINZHI QIZHENG TIBETAN MEDICINE FTY - OTC HEALTHCARE - CHINA
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 23 Tibet Linzhi Qizheng Tibetan Medicine Fty: Key Facts
    • Summary 24 Tibet Linzhi Qizheng Tibetan Medicine Fty: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
  • COMPETITIVE POSITIONING
    • Summary 25 Tibet Linzhi Qizheng Tibetan Medicine Fty: Competitive Position 2006
  • WYETH PHARMACEUTICAL CO LTD - OTC HEALTHCARE - CHINA
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 26 Wyeth Pharmaceutical Co Ltd: Key Facts
  • COMPANY BACKGROUND
  • PRODUCTION
  • COMPETITIVE POSITIONING
    • Summary 27 Summary Wyeth Pharmaceutical Co Ltd: Competitive Position 2006
  • XIAN JANSSEN PHARMACEUTICAL LTD - OTC HEALTHCARE - CHINA
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 28 Xian Janssen Pharmaceutical Ltd: Key Facts
    • Summary 29 Xian Janssen Pharmaceutical Ltd: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
  • COMPETITIVE POSITIONING
    • Summary 30 Xian Janssen Pharmaceutical Ltd: Competitive Position 2006
  • ANALGESICS IN CHINA
  • HEADLINES
  • TRENDS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR DATA
    • Table 15 Sales of Analgesics by Subsector: Value 2001-2006
    • Table 16 Sales of Analgesics by Subsector: % Value Growth 2001-2006
    • Table 17 Herbal vs Standard Topical Analgesics 2001/2006
    • Table 18 Analgesics Company Shares by Retail Value 2002-2006
    • Table 19 Analgesics Brand Shares by Retail Value 2003-2006
    • Table 20 Forecast Sales of Analgesics by Subsector: Value 2006-2011
    • Table 21 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
  • COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN CHINA
  • HEADLINES
  • TRENDS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR DATA
    • Table 22 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
    • Table 23 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
    • Table 24 Sales of Decongestants by Type: Value 2001-2006
    • Table 25 Sales of Decongestants by Type: % Value Growth 2001-2006
    • Table 26 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
    • Table 27 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
    • Table 28 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
    • Table 29 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
    • Table 30 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
    • Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
    • Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
  • DIGESTIVE REMEDIES IN CHINA
  • HEADLINES
  • TRENDS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR DATA
    • Table 33 Sales of Digestive Remedies by Subsector: Value 2001-2006
    • Table 34 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
    • Table 35 Herbal vs Standard Digestive Remedies 2001/2006
    • Table 36 Digestive Remedies Company Shares by Retail Value 2002-2006
    • Table 37 Digestive Remedies Brand Shares by Retail Value 2003-2006
    • Table 38 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
    • Table 39 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
  • MEDICATED SKIN CARE IN CHINA
  • HEADLINES
  • TRENDS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR DATA
    • Table 40 Sales of Medicated Skin Care by Subsector: Value 2001-2006
    • Table 41 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
    • Table 42 Herbal vs Standard Medicated Skin Care 2001/2006
    • Table 43 Medicated Skin Care Company Shares by Retail Value 2002-2006
    • Table 44 Medicated Skin Care Brand Shares by Retail Value 2003-2006
    • Table 45 Acne Treatments Brand Shares by Retail Value 2003-2006
    • Table 46 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
    • Table 47 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
  • VITAMINS AND DIETARY SUPPLEMENTS IN CHINA
  • HEADLINES
  • TRENDS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR DATA
    • Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
    • Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
    • Table 50 Sales of Vitamins by Type: Value 2001-2006
    • Table 51 Sales of Vitamins by Type: % Value Growth 2001-2006
    • Table 52 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
    • Table 53 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
    • Table 54 Vitamins Brand Shares by Retail Value 2003-2006
    • Table 55 Sales of Dietary Supplements by Type: Value 2001-2006
    • Table 56 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
    • Table 57 Dietary Supplements Brand Shares by Retail Value 2003-2006
    • Table 58 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
    • Table 59 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
  • NRT SMOKING CESSATION AIDS IN CHINA
  • HEADLINES
  • TRENDS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR INDICATORS
    • Table 60 Number of Smokers by Gender 2001-2006
  • SECTOR DATA
    • Table 61 Sales of Smoking Cessation Aids by Subsector 2001-2006
  • EYE CARE IN CHINA
  • HEADLINES
  • SECTOR DATA
    • Table 62 Sales of Eye Care by Subsector: Value 2001-2006
    • Table 63 Sales of Eye Care by Subsector: % Value Growth 2001-2006
    • Table 64 Eye Care Company Shares by Retail Value 2002-2006
    • Table 65 Eye Care Brand Shares by Retail Value 2003-2006
    • Table 66 Forecast Sales of Eye Care by Subsector: Value 2006-2011
    • Table 67 Forecast Sales of Eye Care by Subsector: % Value
  • Growth 2006-2011EAR CARE IN CHINA
  • HEADLINES
  • ADULT MOUTHCARE IN CHINA
  • HEADLINES
  • CALMING AND SLEEPING PRODUCTS IN CHINA
  • HEADLINES
  • WOUND TREATMENTS IN CHINA
  • HEADLINES
  • SECTOR DATA
    • Table 68 Sales of Wound Treatments by Subsector: Value 2001-2006
    • Table 69 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
    • Table 70 Wound Treatments Company Shares by Retail Value 2002-2006
    • Table 71 Wound Treatments Brand Shares by Retail Value 2003-2006
    • Table 72 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
    • Table 73 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
  • EMERGENCY CONTRACEPTION IN CHINA
  • HEADLINES
  • SECTOR DATA
    • Table 74 Sales of Emergency Contraception by Subsector: Value 2001-2006
    • Table 75 Sales of Emergency Contraception by Subsector: % Value Growth 2001-2006
    • Table 76 Forecast Sales of Emergency Contraception by Subsector: Value 2006-2011
    • Table 77 Forecast Sales of Emergency Contraception by Subsector: % Value Growth 2006-2011
概要 原文目次
※この商品は英文にてご提供いたします。
【 英文市場調査報告書 】
中国におけるOTC医薬品市場
OTC Healthcare in China
出版日 : 2007/09
電話でのお問い合わせ
この商品について問い合わせる
この商品のサンプル(抜粋)を依頼する
価格

※ドル建て価格の商品のお支払いは、為替レート (TTS: 94.69) 換算による円建てのご請求書にて承ります。

US $ 2,400 換算 -> ¥ 227,256 (税抜) PDF by E-mail (Single User License)
商品コード : 60369